JPH012598A - How to measure calcium - Google Patents
How to measure calciumInfo
- Publication number
- JPH012598A JPH012598A JP62-157587A JP15758787A JPH012598A JP H012598 A JPH012598 A JP H012598A JP 15758787 A JP15758787 A JP 15758787A JP H012598 A JPH012598 A JP H012598A
- Authority
- JP
- Japan
- Prior art keywords
- calcium
- oxalate
- measurement
- oxalic acid
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011575 calcium Substances 0.000 title claims description 35
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims description 34
- 229910052791 calcium Inorganic materials 0.000 title claims description 34
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 45
- 238000005259 measurement Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 7
- 108010063734 Oxalate oxidase Proteins 0.000 claims description 6
- 102000003992 Peroxidases Human genes 0.000 claims description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
- 235000006408 oxalic acid Nutrition 0.000 description 12
- 239000011777 magnesium Substances 0.000 description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 8
- 229910052749 magnesium Inorganic materials 0.000 description 8
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 8
- 229940039790 sodium oxalate Drugs 0.000 description 8
- 229940039748 oxalate Drugs 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000000691 measurement method Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- NEGFNJRAUMCZMY-UHFFFAOYSA-N 3-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=CC(C(O)=O)=C1 NEGFNJRAUMCZMY-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 1
- -1 calcium in serum Chemical compound 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、酵素を用いた間接的カルシウムの測定方法に
関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for indirectly measuring calcium using an enzyme.
カルシウム特に、血清中の微量なカルシウムの定址分析
は、実用基準法である原子吸光法やイオンクロマトグラ
フィーなどがあるが、臨床診断領域においては、Can
na rty−Br igg@の方法を基盤にした、い
わゆるo −cpc法が最も用いられている。Calcium In particular, there are practical standard methods for static analysis of minute amounts of calcium in serum, such as atomic absorption spectrometry and ion chromatography.
The so-called o-cpc method, based on the method of narty-Br igg@, is most commonly used.
しかし、o−cpc法は、共存イオン、特にマグネシウ
ムが、カルシウム測定値にプラス誤差を与える為、8−
オキシキノリンの添加、−領域の厳密な調製などにより
、その影響を排除しているが、完全に満足のいく測定法
ではない。つまり、マグネシウムのいんぺい剤としての
8−オキシキノリンは、その添加量を増加していけば、
マグネシウムの影響は押さえられるが、過量状態になる
と、目的のカルシウムの呈色も相当減少してしまう、ま
た、−範゛囲は1O18〜11.2の範囲にあることが
膳ましいが、よシ正確なカルシウム量を求めるには、そ
の範囲はpH11,0±0.05が理想であシ、そのv
I4I!iは、微妙なる操作を必要とする。さらにo−
cpc法ではタンi4り質の影響を受けるため測定前に
、除タ/ノクク操作も必要とし、操作的にも煩雑であっ
た。However, in the O-CPC method, coexisting ions, especially magnesium, give a positive error to the calcium measurement value.
Although this influence has been eliminated by adding oxyquinoline and strictly preparing the -region, this is not a completely satisfactory measurement method. In other words, if the amount of 8-oxyquinoline added as a magnesium inhibitor increases,
Although the influence of magnesium can be suppressed, if it becomes excessive, the coloration of the target calcium will be considerably reduced. In order to obtain an accurate amount of calcium, the ideal range is pH 11.0 ± 0.05.
I4I! i requires delicate manipulation. Furthermore o-
Since the cpc method is affected by the oxidation quality, it requires removal and removal operations before measurement, making the process complicated.
このように、特に血清中の微量なカルシウムを測定する
場合、o−cpc法では、除タンz4り操作後、共存イ
オン特にマグネシウムの影響を排する為、8−オキシキ
ノリンの添加、モして至適−の厳密な設定を必要とする
。しかしながら、正確なカルシウム量を求めるには、決
っして満足のいく測定法ではない、つまシ過剰の8−オ
キシキノリンの存在によるカルシウムの呈色の減少、及
び至適−範囲外でのカルシウム量の減少並びに厳密な一
般定を要する方法は、日頃のルーチン業務には適してい
ない0本発明は上記のような問題点を解決した正確で操
作の簡易なカルシウムの測定方法を提供しようとするも
のである。In this way, especially when measuring trace amounts of calcium in serum, the O-CPC method requires the addition of 8-oxyquinoline after the detanning operation to eliminate the influence of coexisting ions, especially magnesium. Requires strict optimal settings. However, it is by no means a satisfactory measurement method for determining the exact amount of calcium, as the presence of excess 8-oxyquinoline reduces the coloration of calcium, and the amount of calcium outside the optimal range. A method that requires a reduction in calcium and a strict general definition is not suitable for daily routine work.The present invention aims to provide an accurate and easy-to-operate method for measuring calcium that solves the above-mentioned problems. It is.
本発明者らは、上記測定法の問題点、特にマグネシウム
の影響を避けるべく鋭意研究の結果、カルシウムを沈澱
させるシュウ酸を酸化するシュウ酸オキシダーゼを用い
た、シュウ酸量の酵素的測定法に着目し、カルシウム特
に血清中のカルシウムの測定に応用したところ、従来法
のマグネシウムによる問題点を一挙に解決することを見
出し、本発明を完成した。As a result of intensive research to avoid the problems of the above measurement method, especially the influence of magnesium, the present inventors developed an enzymatic method for measuring the amount of oxalate using oxalate oxidase, which oxidizes the oxalate that precipitates calcium. When this method was applied to the measurement of calcium, particularly calcium in serum, it was discovered that the problems caused by magnesium in the conventional method could be solved at once, and the present invention was completed.
すなわち、本発明はカルシウムをシュウ酸塩として沈澱
せしめ、過剰のシュウ酸をシュウ酸オキシダーゼで酸化
し、発生する過酸化水素にょシ、ペルオキシダーゼの存
在下色原体を発色させ、比色測定することによりカルシ
ウム量を求めること全特徴とする、カルシウム測定方法
である。That is, the present invention precipitates calcium as oxalate, oxidizes excess oxalate with oxalate oxidase, generates hydrogen peroxide, develops a chromogen in the presence of peroxidase, and performs colorimetric measurement. This is a calcium measurement method that is characterized by determining the amount of calcium.
以下、本発明の詳細な説明する。The present invention will be explained in detail below.
本発明においては、カルシウムイオンを含む血清等の試
料に一定量の過剰のシュウ酸又はカルシウム塩よシイオ
ン化の高い水溶性シュウ酸塩を加え、カルシウムイオン
を不溶性のシュウ酸カルシウム塩として沈澱させ、水溶
液中に残存するシュウ酸の量を測定することにより、間
接的にカルシウムの量を測定する。なお、ここにシュウ
酸とは水溶性シュウ酸塩として存在するシュウ酸が含ま
れる。モしてシュウ酸の定量には、シュウ酸オキシダー
ゼにより過酸化水素を発生させペルオキシダーゼの存在
下色原体を発色させる比色測定法を用いる。In the present invention, a certain amount of excess oxalic acid or a calcium salt or a highly ionized water-soluble oxalate is added to a sample such as serum containing calcium ions, and the calcium ions are precipitated as an insoluble calcium oxalate salt. The amount of calcium is measured indirectly by measuring the amount of oxalic acid remaining in the aqueous solution. Note that oxalic acid here includes oxalic acid that exists as a water-soluble oxalate. To quantify oxalic acid, a colorimetric method is used in which hydrogen peroxide is generated by oxalate oxidase and a chromogen develops color in the presence of peroxidase.
本発明の反応系路は、以下の通りである。The reaction system of the present invention is as follows.
Ca”+Na2C204−* CaC2O4↓十過剰な
020 m ’ −+ 2N a ”シュウ酸オキシダ
ーゼ
C2O4”+2H++0 2CO2+H
2O2ノ母ルオキシダーゼ
H2O2+色原体 発色体+H2゜本
発明に用いられる水溶性シュウ酸塩としてはシ、つ酸ナ
トリウム、シュウ酸アンモニウム尋であシ、好ましくは
JIS−次標準であシ、純度的にも信頼をおける点から
シュウ酸ナトリウムが用いられる。Ca"+Na2C204-* CaC2O4↓10 excess 020 m' -+ 2N a "Oxalate oxidase C2O4"+2H++0 2CO2+H
2O2 base oxidase H2O2 + chromogen chromogen + H2゜The water-soluble oxalate used in the present invention is sodium oxalate, ammonium oxalate, preferably JIS-secondary standard, purity. Sodium oxalate is used because of its reliability.
本発明が血清に対して実施される場合においては、シュ
ウ酸は好ましくはシュウ酸ナトリウムの10〜40 m
mol/A! の水性試液として用いられ、特に好まし
い濃度は30 mmol/Jである・本発明におけるシ
ュウ酸の比色測定はCl1n。When the invention is practiced on serum, the oxalic acid is preferably 10 to 40 m of sodium oxalate.
mol/A! The particularly preferred concentration is 30 mmol/J.The colorimetric measurement of oxalic acid in the present invention is performed using Cl1n.
Ch@n、、29ニア00−702.1983等に詳述
されておシ、色原体や測定操作等も一般に用いられてい
るものが利用可能である。Ch@n, 29 Nia 00-702.1983, etc., and the chromogens, measurement operations, etc. that are commonly used can be used.
シュウ酸の比色測定に用いられる試薬としては例えば以
下の如きものが例示される・
・シ、つ酸測定試薬A
尿、中シュウ酸測定法キットである“シュウ酸「アスカ
・シグマ」#(アスカ紬薬(株)製)f:用い、以下の
濃度になるよう試薬調製した。Examples of reagents used for colorimetric measurement of oxalic acid include the following: Oxalic acid measurement reagent A Urine, oxalic acid measurement kit “Oxalic acid “Asuka Sigma” # ( (manufactured by Asuka Tsumugi Co., Ltd.) f: was used, and the reagent was prepared to have the following concentration.
3−(ジメチルアミノ)ベンゾイックアシッド :
3.0mmolペルオキシダーゼ
:5000U/lシユウ酸オキシダーゼ
: 100U/J3−メチル−2−ベ
ンゾチアゾリノンヒドラゾン : 0.2mmolト
リス緩衝液 : 0
.1mmol(測定波長590nm)
〔実施例〕
以下、実施例によシ更に具体的に説明する。3-(dimethylamino)benzoic acid:
3.0mmol peroxidase
:5000U/l oxalate oxidase
: 100U/J3-methyl-2-benzothiazolinone hydrazone : 0.2mmol Tris buffer : 0
.. 1 mmol (measurement wavelength 590 nm) [Example] Hereinafter, a more specific explanation will be given based on an example.
一実施例1−
カルシウム標準液(10,019/di)に、マグネシ
ラAl #13.415.10$15*100mmol
/j!となるよう試料を調製し、以下の測定方法でカル
シウムを定量した。Example 1 - Magnesilla Al #13.415.10$15*100 mmol in calcium standard solution (10,019/di)
/j! A sample was prepared so that the calcium content was quantified using the following measurement method.
試料溶液、精製水(盲検用)及び標準溶液各200μノ
に30 mmol/lのシュウ酸ナトリウム試薬50μ
l’に加え室温に60分間放置した。シュウ酸ナトリウ
ム試液とカルシウムの至適反応時間は、室温におい【1
0分間でほぼ反応は終了するが、より精度を上げるため
に60分間とした。(第1図参照図中、イ、口、ハ、二
はシュウ酸ナトリウム濃度がそれぞれイ: 10 mm
ol/l、口: 20mmol/l。Add 50μ of 30 mmol/l sodium oxalate reagent to 200μ each of sample solution, purified water (for blind testing), and standard solution.
l' and left at room temperature for 60 minutes. The optimal reaction time between sodium oxalate test solution and calcium is [1] at room temperature.
Although the reaction was almost completed in 0 minutes, it was set to 60 minutes to improve accuracy. (See Figure 1. In the diagram, A, C, C, and B indicate the sodium oxalate concentration, respectively. A: 10 mm
ol/l, oral: 20 mmol/l.
ハ: 30 mmol/l、二: 40 mmol//
のグラフである。)カルシウム濃度は10 m9/dl
でおる。遠心分離後上清20μEに前記シュウ酸測定試
薬A0.5mjt−加え37℃、40分間加温する。次
に、精製水5dを加え、精製水を対照に590 nmで
比色定置し、共存マグネシウムの影響を観たところ、表
1に示すごとく全く、影響は無かった。C: 30 mmol/l, 2: 40 mmol//
This is a graph of ) Calcium concentration is 10 m9/dl
I'll go. After centrifugation, 0.5 mjt of the oxalic acid measurement reagent A was added to 20 μE of the supernatant, and the mixture was heated at 37° C. for 40 minutes. Next, 5 d of purified water was added, and colorimetry was performed at 590 nm using the purified water as a control to examine the effect of coexisting magnesium. As shown in Table 1, there was no effect at all.
表 1
共存Mg濃度(mmo 1/l) カルシウム定
量値(1t)1 1
0.042 10.053
10.004
9.975
9.9610 1
0.0515 9.9910
0 9.98一実施例2一
実施例1に従い、血清中のカルシウムを測定した。また
比較のため従来法のo−cpc法でも測定した。結果を
表2に示す。Table 1 Coexisting Mg concentration (mmo 1/l) Calcium quantitative value (1t) 1 1
0.042 10.053
10.004
9.975
9.9610 1
0.0515 9.9910
0 9.98 - Example 2 - According to Example 1, calcium in serum was measured. For comparison, measurements were also made using the conventional O-CPC method. The results are shown in Table 2.
表 2
表2に示す如く、本流の測定値と、従来法による測定値
との間には、良好な相関性が認められた。Table 2 As shown in Table 2, a good correlation was observed between the mainstream measurement values and the conventional method measurement values.
(y =1.0183!−0,10−r=0.984)
〔発明の効果〕
本発明のカルシウムの定量法は、その含有試料に試薬を
添加し、反応終了後比色測定するだけで、従来法におけ
る、除タン74’り操作、マグネシウムの影響を排する
為のいんぺい剤添加によるカルシウム呈色の減少、至適
−の設定の煩雑性などの問題点を解消し、精度良くカル
シウムの定量を行うことが可能となった。(y = 1.0183!-0,10-r=0.984)
[Effects of the Invention] The method for quantifying calcium of the present invention simply adds a reagent to a sample containing the calcium and performs colorimetric measurement after the completion of the reaction, thereby eliminating the effects of sputum removal and magnesium in conventional methods. Problems such as the reduction in calcium coloring due to the addition of a preservative and the complexity of optimal settings have been resolved, and it has become possible to quantify calcium with high accuracy.
第1図は、シュウ酸ナトリウム溶液とカルシウムとの反
応時間をシュウ酸ナトリウムの濃度別にその関係を表わ
したグラフであるー
放llq場C分】Figure 1 is a graph showing the relationship between the reaction time of sodium oxalate solution and calcium depending on the concentration of sodium oxalate.
Claims (1)
ウ酸をシュウ酸オキシダーゼで酸化し、発生する過酸化
水素により、ペルオキシダーゼの存在下、色原体を発色
させ、比色測定することによりカルシウム量を求めるこ
とを特徴とする、カルシウム測定方法。Calcium is precipitated as oxalate, excess oxalate is oxidized with oxalate oxidase, the generated hydrogen peroxide develops a chromogen in the presence of peroxidase, and the amount of calcium is determined by colorimetric measurement. A method for measuring calcium, characterized by the following.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62-157587A JPH012598A (en) | 1987-06-26 | How to measure calcium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62-157587A JPH012598A (en) | 1987-06-26 | How to measure calcium |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS642598A JPS642598A (en) | 1989-01-06 |
JPH012598A true JPH012598A (en) | 1989-01-06 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kageyama | A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system | |
JPS5823079B2 (en) | Analytical methods and means for determining the amount of hydrogen peroxide in an aqueous medium and the amount of organic substrates that generate hydrogen peroxide by enzymatic oxidation | |
CN104596959A (en) | Method for detecting potassium ion concentration based on DNA enzymes | |
Ishihara et al. | Enzymatic determination of ammonia in blood plasma | |
US3862885A (en) | Determination of uric acid in blood with uricase | |
Trivedi et al. | New ultraviolet (340 nm) method for assay of uric acid in serum or plasma. | |
JPH012598A (en) | How to measure calcium | |
JP2994831B2 (en) | Cholesterol assay and reagents | |
Kuan et al. | An alternative method for the determination of uric acid in serum | |
JPH03187400A (en) | Method and reagent for optically measuring bilirubin | |
JP2515551B2 (en) | Novel method for quantifying hydrogen peroxide | |
CN115655848B (en) | Stable glutamic-oxaloacetic transaminase determination kit | |
JP3702545B2 (en) | Chemiluminescent reagent | |
WO1994023061A1 (en) | Method of determining sodium ion | |
JPS5966899A (en) | Determination of hydrogen peroxide | |
JPH0343096A (en) | Determination of substrate or enzyme | |
JPS6167499A (en) | Method and reagent for determination of catalase activity in blood | |
JPS63160600A (en) | Reagent for determining pyruvic acid | |
JPH0772157A (en) | Method and kit for determination of saccharified protein | |
JPS5856698A (en) | Improved method for quantitative determination of substrate or enzyme | |
Aw | An enzymatic method for glucose estimation using the starch-iodine chromogen | |
JPH0365160B2 (en) | ||
JPS6352060A (en) | Method and kit for quantitative determination of indirect bilirubin | |
JPH062079B2 (en) | Determination method of magnesium | |
JPH02200200A (en) | Determining method of nadh and determination of bile acid using the same method |